Authorization

CytoDyn to Present at BIO CEO & Investor Conference 2019 on February 11

VANCOUVER, Washington, Feb. 08, 2019 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), CytoDyn, a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, announces that it will be presenting a company overview at BIO CEO & Investor Conference 2019 on Monday, February 11, at 9:45 a.m. Eastern time (6:45 a.m. Pacific time).A  The conference is being held at the Marriott Marquis Hotel in New York City.
The BIO CEO & Investor Conference is an international biotech investor conference focused on established and emerging publicly traded and select private biotech companies.A  More information regarding the conference can be found at https://www.bio.org/events/bio-ceo-investor-conference.The presentation by CytoDyn management is Monday, February 11, at 9:45 a.m. ET.A  A live webcast and replay of the presentation at BIO CEO will be available on the Investors section of the Companya??s website, https://ir.cytodyn.com/. The webcast will be available approximately one hour after the webcast presentation ends and will be accessible for 90 days.CONTACTSInvestors:
Nader Pourhassan, Ph.D.
President & CEO
360-980-8524
npourhassan@cytodyn.com
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Сентябрь 2019    »
ПнВтСрЧтПтСбВс
 1
2345678
9101112131415
16171819202122
23242526272829
30